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The immune system is present in all tissues of the human body. In order to respond 
appropriately to infections, cells of the innate and adaptive immune system work in concert. 
In this thesis, we focused on natural killer cells (NK cells) and mucosa associated invariant T 
cells (MAIT cells), that are both present in peripheral blood and enriched in certain tissues 
such as the liver and, in case of NK cells, also the uterus where they are thought to be 
important regulators at the maternal-fetal interface. NK cells are able to react readily towards, 
among other things, virus-infected cells whereas MAIT cells are triggered by both cytokines 
in viral infections and bacterial metabolites during bacterial infections. Hepatitis C virus 
(HCV) is a major cause of chronic viral hepatitis and is known to impact the immune system 
at several instances in order to establish chronic infection. Yet, with recent advances in anti-
viral treatment, the infection can now be cured in a short period of time. As a result of this, it 
is possible to study the impact of HCV on the immune system in a dynamic setting. Therefor 
we investigated both NK cells and MAIT cells in HCV before, during, and after viral 
clearance of the infection. Despite rapid clearance of virus, imprints inflicted by chronic HCV 
infection remained within NK cells and MAIT cells over time. More specifically, MAIT cells 
were dysfunctional, present at a reduced frequency, and displayed an altered phenotype that 
was only partially restored upon infection clearance. Along similar lines, also the NK cell 
phenotype and the diversity of the NK cell compartment remained altered after rapid HCV 
viral clearance. We observed persistently reduced intraindividual diversity of NK cells after 
elimination of chronic HCV, whereas the interindividual diversity, more linked to liver 
damage, was restored over time. Next, we studied peritoneal MAIT cells in ascites of patients 
with liver cirrhosis on the basis of viral hepatitis and other causes, and in the context of 
spontaneous bacterial peritonitis (SBP), a frequent and severe complication occurring in these 
patients. First, we could recapitulate the loss of MAIT cells in peripheral blood of cirrhosis 
patients in line with previous studies. Of note, in ascites, MAIT cells were more frequent than 
in blood and displayed a tissue-residency phenotype with increased functionality as compared 
to peripheral blood MAIT cells. Strikingly, during SBP, MAIT cells were the most recruited 
immune cells to the peritoneal cavity. Lastly, we investigated uterine NK cells (uNK cells) 
and hypothesized that these cells underwent a stepwise differentiation in response to 
endometrial regeneration and pregnancy. We present a model where uNK cells continuously 
differentiate throughout the menstrual cycle. This differentiation was associated with a 
functional shift towards immunomodulation and enhanced angiogenic function, possibly to 
aid in spiral artery formation during pregnancy. 
In conclusion, we present data suggesting that chronic infections can leave a long-lasting 
imprint on the immune system. We further demonstrate that immune cell frequency, 
phenotype, and function can be altered depending on the respective tissue the cells reside in. 
This work increases our understanding of how innate lymphocytes respond to environmental 
cues, such as acute or chronic viral and bacterial challenges, as well as to normal 
physiological processes of the human body.  
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1.1 THE IMMUNE SYSTEM 
Nowadays it is known that mankind lives in close contact to innumerous microbial organisms. 
These can be either beneficial or, in some cases, a threat to the body’s integrity. Most of bacteria 
and fungi live in harmony with mankind and many can colonize either our skin or internal 
(mucosal) surfaces. Yet, some bacteria and fungi, as well as nearly all viruses and parasites, 
can disrupt our body’s integrity and thus threaten our health. Then it is the immune system’s 
task to defend us. Furthermore, the immune system shields the body not only against external 
microbial harms, but it can also recognize and eliminate internal threats such as cancer. Recent 
research also points to relevant interactions between immune cells and tissues they reside in. 
Even if not all functions of the immune system can be mentioned here, it becomes evident that 
this fascinating network of cells and soluble factors is essential for human survival and 
wellbeing.  
1.2 THE ADAPTIVE AND THE INNATE PART OF THE IMMUNE SYSTEM.  
The cells of the human immune system can be classified into an adaptive and an innate branch. 
The adaptive arm contains T and B cells, whereas monocytes, macrophages, natural killer (NK) 
cells, granulocytes, dendritic cells, and mast cells belong to the innate part 1,2. This 
classification derives mainly from the ability of adaptive immune cells to identify the body’s 
own (self) and foreign structures (non-self) for which they undergo a selection process during 
their development 3,4. Innate immune cells on the other hand, react immediately to certain 
stimuli without being primed beforehand for the discrimination between self and non-self 1. Of 
course, these here described parts of the immune system work together closely and some cells, 
like dendritic cells, are part of the innate immune system but their main function is to interact 
with cells of the adaptive immune system 2.  
1.3 THE ADAPTIVE IMMUNE SYSTEM 
With their ability to recognize structures that do not belong to the body, adaptive immune cells 
are made for specifically targeting and thus eliminating those. To this end, B cells and T cells 
have different functions: B cells produce antibodies 5, soluble proteins that can bind to foreign 
structures and highlight them to other immune cells or directly neutralize them. T cells on the 
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other hand consist of many subsets that can, in short, either regulate the immune response or 
directly target cells for destruction. These functions will be described later in more detail.  
The molecules recognized by the adaptive immune system are called antigens and the specific 
binding sites referred to as epitopes. Antigens are presented to B and T cells on the so called 
major histocompatibility complex (MHC) which is synonymous with the human leukocyte 
antigen (HLA). When the antigen is of foreign (thus microbial) origin, antigen presenting cells 
(APC) such as monocytes and DCs take up and process the exogenous antigens and present 
them on MHC class II6. Especially DCs play a central role in antigen presentation and T cell 
activation, which is why they form an important link between the innate and the adaptive part 
of the immune system 2. Endogenous self antigens, such as cancerous structures, are presented 
on MHC class I which is expressed broadly by nearly all cells 6. Yet, there are exceptions to 
the rule of self-antigens being presented on MHC class I, as some APCs are able to present also 
exogeneous antigens on MHC class I, a process called cross-presentation 7. 
The key to this highly specific recognition of self and non-self antigens originates in the B cell 
receptor (BCR) and the T cell receptor (TCR) found on the respective cells. Each B or T cell 
expresses just one BCR or TCR. To ensure that all possible antigens are recognized, an 
enormous number of different T and B cells and respective receptors are necessary. To achieve 
this immense diversity, during B and T cell development, somatic recombination of a set of 
genes takes place8. In short, several genes can be combined in different ways so that an 
extremely high diversity of these receptors is possible. Some exceptions to this diversity have 
developed within the adaptive immune system. Unconventional T cells, to which mucosal-
associated invariant T cells (MAIT cells) also belong, display a much more restricted TCR 
repertoire9. These cells and their function will be mentioned in more detail later. Thus, certain 
cells do not reflect all of the features of their class. As all immune cells have to work together 
in eliminating or controlling pathogens, contact points between the adaptive and the innate part 
of the immune system are crucial. 
1.3.1 T cells  
In the adaptive part of the immune system, T cells represent one major cell type. They can be 
classified according their functionality and receptor expression pattern into CD3+CD4+ T 
helper cells that produce immunomodulating cytokines and cytotoxic CD3+CD8+ T cells 
(cytotoxic T lymphocytes) which can lyse target cells directly10. T cells can be further 
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subdivided into naïve cells that have not yet encountered foreign antigen and memory T cells 
that already experienced activation upon antigen recognition. Memory T cells can be activated 
more easily and are fast to respond if they encounter the same antigen again11,12. Yet, also 
memory T cells are a heterogeneous group and can be classified according their expression of 
CCR7 and CD45RA in central memory (TCM), effector memory (TEM), and effector memory 
RA (TEMRA) 13. 
Within CD4+ T cells exist subpopulations with specific features. First, regulatory T cells (Treg) 
can be identified by their expression of CD25, the transcription factor FOXP3, and the lack of 
CD12714. As their name indicates, they are specialized in dampening immune responses and 
mediating tolerance14. Second, T follicular helper cells, marked by the expression of CXCR5 
and PD-1, contribute to germinal center reactions promoting B cell maturation, but can also be 
found in periphery15. 
1.3.2 Unconventional T cells 
While conventional T cells are able to recognize a great variety of possible antigens, 
unconventional T cells, such as NKT cells, gdT cells, and MAIT cells, are restricted in their 
TCR repertoire and thus in their recognition of antigen 9. They are able to exert effector 
functions faster than conventional T cells and to respond to molecules other than peptides, but 
do not form memory cells 9. NKT cells respond among others to bacterial lipids presented on 
the CD1d molecule 16, indicating that they are able to respond to bacterial infections. In line, 
also gdT cells recognize microbe originating molecules 17 but also get activated by cellular 
stress signals such as MICA and ULBPs 18,19. Thus, unconventional T cells appear to take over 
functions that are typically more associated with the innate immune system and represent a 
faster response against pathogens. 
1.3.3 MAIT cells 
Belonging to unconventional T cells, MAIT cells uniformly express the TCR Vα7.2 segment 
and possess furthermore only a limited TCR Vβ chain repertoire 20,21. The antigens recognized 
by this rather restricted TCR repertoire are predominantly riboflavin metabolites that are 
presented by the MHC class 1-like molecule MR121,22. As these metabolites derive from 
bacteria or fungi, the assumed main functional role of MAIT cells is to respond to bacterially 
infected cells 22,23. Yet, MAIT cells are not limited to bacterial infections in their response as 
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they are also able to recognize fungal organisms 24 and be activated by cytokines such as IL-7, 
IL-12, and IL-18 typically produced during viral infections 21,25,26. Another identifying feature 
of MAIT cells is the expression of CD161 27. This receptor (previously also called NKR-P1A) 
was discovered to be expressed on NK cells and a subset of T cells 28 and appears to correlate 
to a “innate-like” signature 29. Thus, despite belonging to adaptive T cells, MAIT cells can also 
be referred to as innate, or innate-like T cells, given their limited TCR repertoire and the innate 
effector functions they acquire already early in life 30.  
Even though present in peripheral blood, MAIT cells, as their name suggests, are enriched in 
mucosal surfaces 20, but even more so in the liver where they can represent up to 50% of all T 
cells 27. For a yet unknown reason, especially during chronic infections 31,32 or inflammatory 
conditions 33,34 the abundance of MAIT cells can drop dramatically. The relevance of this loss 
of MAIT cells is currently unknown, but it is hypothesized that in chronic infections this loss 
might render patients more susceptible to additional infections and therefor adds to the burden 
on the immune system in chronically infected patients35.  
MAIT cells in viral infections 
Despite their predisposition to react during bacterial infections, MAIT cells are contributing 
also to anti-viral immunity. This has been studied for example in influenza, where higher MAIT 
cell numbers correlate with clinical outcome 36 but also in murine models where they protected 
from lethal disease 37. Additionally, MAIT cells are also activated in other viral infections, such 
as those by dengue virus 38 and HIV 31,39, and thought to contribute to the immune response. 
As these viruses do not share common features but instead represent quite distinct families, it 
appears that MAIT cells are a common part of the immune response towards viral infections. 
1.4 THE INNATE IMMUNE SYSTEM 
As already mentioned, the human immune system consists also of cells that do not undergo a 
development to distinguish self and non-self structures. These cells form the innate immune 
system. Yet, it would be wrong to say that the innate immune system cannot tell apart foreign 
and the body’s own antigens, as innate immune cells can express different receptors, as for 
example the pattern-recognition receptors, that react specifically to bacterial or viral 
structures40. The difference is more that adaptive immune cells have a variety of possible 
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antigen receptors and undergo selection to discern the body’s own and foreign structures 
whereas innate immune cells express the same kind of receptors without selection. 
1.4.1 NK cells  
Belonging to innate immune cells, one key feature of NK cells is their ability to lyse target cells 
directly and without preceding sensitization, hence their name “natural killer cells”. They 
represent roughly 10 % of all lymphocytes in circulation and are defined as CD56+CD3- 
lymphocytes that can be subdivided according their expression level of CD56 into CD56dim 
and CD56bright NK cells41. The function of CD56 itself is still topic of current research, though 
it appears to be relevant for their ability to form a lytic synapse when lysing target cells 42. The 
afore mentioned subsets, CD56dim and CD56bright NK cells, also differ in their expression of 
the Fc receptor CD16, which is highly expressed on CD56dim but found only at low levels on 
CD56bright NK cells41. This results also in different functional capacities, as CD56dim NK 
cells are more potent in target cell lysis and antibody-dependent cytotoxicity (ADCC) whereas 
CD56bright NK cells produce more cytokines and have a higher proliferative potential41. 
The function of NK cells is regulated by a variety of inhibitory and activating receptors. 
Common activation receptors are CD16, NKp46, NKp44, NKp30, DNAM-1 and NKG2D, 
whereas inhibitory receptors are NKG2A, LILRB1 and most of the killer cell immunoglobulin-
like receptors (KIR) 41,43. The expression pattern and the levels of these are important, as the 
resulting balance of activating and inhibiting signals determines NK cell function 44. A unique 
feature of NK cells is that some of these inhibitory receptors are able to recognize MHC on 
target cells. Thus, a lack of MHC on a target cell leads to activation of the NK cell, a mechanism 
which is called “missing-self” recognition 45. The biological significance becomes evident in 
the case of tumors or infected cells: downregulation of MHC might enable escape from T cell 
mediated lysis, but NK cells would then sense this “missing-self”, become activated and lyse 
the target cell. 
KIR receptors 
KIR receptors are expressed mainly on NK cells and are single immunoglobulin chains that 
can transmit either inhibitory or activating signals46,47. They recognize parts of the MHC class 
1 (in this context referred to as KIR-ligands (KIRL)) and are thus crucial for the NK cells’ 
ability to recognize the absence of MHC45,48. 
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Similar to the MHC system, also KIR receptors are encoded by highly diverse genes and each 
individual person has a specific genotype49,50. According to the given genotype of KIRs, two 
main haplotypes can be distinguished: KIR haplotype A which only consists of the combination 
KIR2DL1, -2DL3, -2DL4, -2DP1, -2DS4, -3DL1, -3DL2, -3DL3 and -3DP1, whereas all other 
KIR genotypes belong to KIR haplotype B 51,52. Within the haplotypes one can further 
differentiate according to gene localization on chromosome 19: whereas KIR haplotype A 
always has centromeric and telomeric A, a KIR haplotype B could be either centromeric 
A/telomericB, centromeric B/telomeric A, or centromeric B/telomeric B53. This is of functional 
importance, as for example the telomeric haplotype B has been associated with reduced CMV 
reactivation after kidney transplantation54 and a centromeric B with protection from 
preeclampsia55. Yet it is not only the KIR and their pattern that matter but also their cognate 
ligands. For HLA-C there exist two allotypes that are recognized: HLA-C1 which is bound by 
KIR2DL2/-2DL3 and HLA-C2 bound by KIR2DL1 and -2DS156. Further known ligands are 
the HLA-B allotypes Bw4 for KIR3DL1 and HLA-G for KIR2DL456. The relevance of the 
KIR-KIRL interaction is highlighted in hepatitis C virus infection (HCV), where it has been 
shown that the combination of KIR2DL3 with a homozygous C1/C1 allotype correlates with 
clearance of the virus57. Except for this, in the last years, many associations between KIR-KIRL 
combinations and disease outcomes have been identified58. This not only implies that NK cells 
in some way are involved in these conditions but also that the KIR-KIRL system is a crucial 
regulating element. 
NK cell maturation, licensing, and expansions 
In investigations on the impact of KIR and KIRL on NK cell functionality, a phenomenon 
known as “licensing” or “education” was uncovered. If NK cell development takes place with 
a KIR present on the NK cells and its cognate KIRL expressed by the host, these NK cells 
become “licensed” and are eventually more potent in lysing MHC-deficient NK cells and 
cytokine production59-61 compared to NK cells positive for KIR without a cognate KIRL 
expressed by the host. This process on the other hand is uncoupled from NK cell maturation. 
NK cells in peripheral blood differentiate from KIR-CD57-NKG2A+ CD56bright NK cells 
over CD56dim cells that acquire CD57, downregulate NKG2A expression to finally become 
CD56dim KIR+CD57+NKG2A-62. Yet this might not hold true for tissue residing cells, as the 
phenotype of NK cells in tissues is not always compatible with this model established for 
peripheral blood 63,64. 
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One viral infection that is highly relevant for NK cells and can substantially imprint this 
compartment is cytomegalovirus (CMV) infection. It has been shown that NK cells acquire 
adaptive features that after the first exposure would protect from CMV in a murine setting 65. 
Furthermore, in humans, the NK cells’ KIR haplotype correlates with the frequency of CMV 
reactivations after stem cell transplantation66. This indicates that NK cells are crucial for control 
of CMV infection. Subsequently, it became evident that human NK cells would in roughly 
30% of all CMV infections develop expansions with a distinct phenotype of NKG2C+ 
CD56dim NK cells which express highly selective KIRs and readily respond to CMV infected 
cells 67,68. These expansions are very stable over time, appear to be affected by strain specific 
peptides 69 and can be linked to epigenetic modifications of the NK cells70. 
1.5 LYMPHOCYTES IN CIRCULATION AND IN TISSUES 
In the recent years, more focus has been shifted towards immune cells that are tissue resident. 
In anatomy, one distinguishes between circulation (that is peripheral arterial and venous blood), 
primary lymphoid organs (thymus and bone marrow) and the secondary lymphoid organs 
(lymph nodes and spleen). In the tissue, lymphoid fluid containing also immune cells is drained 
by lymph vessels via several lymph nodes and finally reentering blood circulation. Previously, 
the majority of immunological research had been done on lymphocytes from peripheral blood, 
mostly because of constraints in access to peripheral tissues. Within a tissue, resident immune 
cells can be identified by expression of CD49a, CD103, as well as the C-type lectin CD69 63,71. 
CD49a and CD103 are integrins that bind extracellular collagen 72 or E-cadherin on epithelial 
cells 73, respectively, whereas CD69 acts as inhibitor of sphingosine 1-phosphate receptor-1 
that mediates lymphocyte egress from tissues 74,75. Thus, these markers act together in retaining 
lymphocytes within peripheral tissues. With respect to CD8 T cells, tissue resident populations 
have been reported that are retained in tissues and do not recirculate to peripheral blood 76. This 
is of interest, as one can hypothesize that certain cells primarily participate in local immune 
response whereas others surveil circulation.  
1.6 THE UTERUS 
The human reproduction poses a dilemma to the immune system: On one hand, during 
pregnancy, the contact of the fetus, via the placenta, to the maternal side is essential, even 
though fetal antigens could be recognized as non-self and rejected. On the other hand, 
infections in the female reproduction tract need to be identified and cleared. All this takes place 
in the uterus and the residing immune cells thus have to tolerate to a certain degree non-self 
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tissue during pregnancy, to follow the uterus’ changes throughout the menstrual cycle and 
pregnancy and still be able to protect it from infections.  
To start with, the uterus itself consists of three layers – the perimetrium, the outer layer covering 
it, the myometrium which is the muscular layer in the middle and as inner lining the 
endometrium, the mucosal surface of the uterus. From an immunological point of view, 
especially the endometrium is of interest as it is here where the fertilized egg first implants and 
the essential contact is created. In pregnancy, the endometrium differentiates into the decidua, 
the maternal part of the placenta. 
After implantation, cells from the outer layer of the embryo differentiate into the so-called 
villous trophoblast (VT), covering the fetal villi that are in contact with the maternal blood in 
the placenta, and the extra-villous trophoblast (EVT) that migrates into the maternal tissue and 
participates in arterial remodeling 77. Thus, the trophoblast cells are crucial in creating the 
maternal-fetal interface, enabling exchange of oxygen and nutrients between the maternal and 
fetal side and creating a tolerogenic environment 78,79. Because the fetal-derived trophoblast 
cells interact with maternal immune cells they have evolved unique adaptations. To this end, 
trophoblast cells express a unique profile of HLA molecules that minimizes T cell recognition, 
with VT not expressing any HLA and EVT lacking selectively HLA-A, -B, and HLA class II 
80. In addition, further ways to suppress immune reactions are described such as production of 
TGFb and VIP 81,82. Those HLA that are expressed by EVT are recognized by NK cell 
receptors, indicating a possibly skewed interaction between EVT and immune cells towards 
tissue residing NK cells 83.  
1.6.1 Uterine NK cells 
The hypothesized interaction between trophoblast and NK cells is strengthened by the fact that 
NK cells are found in the uterus in frequencies exceeding those in peripheral blood 64. NK cells 
are already present in the endometrium at a high frequency and then increase in numbers in 
early pregnancy in the decidua84,85. Not only do NK cell frequencies differ from peripheral 
blood but NK cells residing in the uterus also display a distinct phenotype 84. These so called 
uterine NK cells (uNK cells) express high levels of NKG2A, are negative for CD16 and CD57 
but express a high percentage of KIR 64. In contrast, in peripheral blood such a phenotype with 




Studying the KIR receptors on NK cells, there are correlations between KIR-KIRL interactions 
and pregnancy disorders such as preeclampsia 87 and low birth weight 88. Notably, uNK cells 
express KIRs at different frequencies and combinations than conventional NK cells (cNK cells) 
in peripheral blood 89,90. The KIRs expressed are also further skewed towards expressing more 
KIR2DL isoforms and less KIR3DL1 86,91. The resulting function of uNK cells seems to be 
linked to the trophoblast invasion and regulation of placental blood supply 92, but it has also 
been suggested that they might secrete factors that directly influence fetal growth 93. In 
summary, uNK cells are specialized for the uterine environment and the interaction with the 
fetal side and appear to be pivotal in the uterine immune system. However, many aspects of 
uNK cell biology remains elusive including if these cells undergo any type of differentiation in 
response to endometrial regeneration and decidual transformation. 
1.7 THE LIVER, ITS IMMUNE SYSTEM AND ITS PATHOLOGIES 
The liver is an organ with a variety of functions including storing nutrients, clearing potentially 
hazardous agents, and producing molecules part of inflammation/infection control, such as C 
reactive protein (CRP). Some of these functions, such as storage of nutrients, can be explained 
by the liver’s anatomy, as most of the blood from the intestine first passes from the portal vein 
through the liver before continuing its journey throughout circulation. Thus, the liver is exposed 
to everything that is passed on to the blood from the intestine. Potentially hazardous agents are 
then cleared by the liver to the bile, which ends in the small intestine and finally get excreted 
through feces.  
Furthermore, the portal venous blood flow also leads to immune cells in the liver coming in 
contact with antigens from the gut. In addition, harms to the liver need also to be handled by 
the local immune system. Therefor the liver is not only an important site in metabolism but 
also in immunology as both tolerance but also immune reactions can be initiated here 94. To 
this end, it harbors a special composition of immune cells: among T cells, MAIT and gdT cells 
are more abundant 27,95, but also NK cells are more frequent than in blood 96,97. Additionally, 
liver resident NK cells possess a distinguished phenotype as CD16- CXCR6+ CD69+ CD49e- 
NK cells 98,99, that is present only at low frequency in peripheral blood. Within the myeloid 
compartment, there are specialized macrophages, so called Kupffer cells, that are resident in 
the liver 100, and other monocytes that can be recruited from peripheral blood 101. Thus, it 
becomes clear that in the liver a certain immunological milieu is created in order to maintain 
tissue function and to mount an adequate immune response. 
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1.7.1 Viral infections of the liver 
There are many pathologies that involve the liver, either primarily or indirectly. Yet, the 
majority of all chronic liver pathologies derives either from primarily liver affecting viruses 
(hepatotropic viruses) such as hepatitis B and C virus (HBV and HCV) or inflammatory 
conditions like autoimmune hepatitis 102 and alcoholic- and non-alcoholic steatohepatitis (ASH 
and NASH, respectively) 103,104. Viral infections can harm the liver either directly, as the virus 
infects liver cells (hepatocytes) and can in consequence induces cell death, or indirectly through 
immune cells that recognize and lyse infected cells. Furthermore, one can distinguish viruses 
that cause primarily acute infections (hepatitis A and E) or those that are prone to establishing 
chronic infections, such as HBV, HCV, and hepatitis D (HDV). The latter, HDV, is not able to 
replicate by itself, instead it needs a co-infection with HBV (either prior to HDV contact or 
simultaneously) 105. Notably, HBV and HCV make up the majority of all chronic viral hepatitis 
infections 106. Yet, they derive from different virus-families and in consequence there are 
profound differences between these two infections 107. While HBV is frequently vertically 
transmitted and leads in this setting nearly always to chronic infection, in adults the majority 
of infected patients recover 108. In contrast, in HCV, vertical transmission is less frequent and 
adult infections become chronic in most cases 108,109.  
1.7.2 Hepatitis C virus 
HCV is a single stranded RNA virus that often causes chronic infection110,111. A chronic 
infection with HCV can ultimately, in selected patients, lead to liver cirrhosis and development 
of hepatocellular carcinoma (HCC) 112. Hepatitis C virus can be classified into six genotypes 
and genotype distribution varies geographically. The most prevalent genotypes in Europe and 
North America are genotypes 1 and 3, whereas genotype 4 is more prevalent in North Africa 
and Middle East113. These different genotypes are important to determine since they influence 
the disease outcome 114.  
In order to establish a chronic infection in first place, HCV has mechanisms to undermine and 
hamper the immune response. For example, CD8+ T cells can progress into an exhausted state 
which is marked by profound phenotypic and functional changes. These exhausted T cells 
display reduced ability to proliferate 115 and lower production of cytokines 116. They also show 
upregulation of inhibitory receptors such as PD-1, TIM-3, and CTLA-4117-120, all of which 
reduce the functionality of HCV specific T cells. Of interest, blocking the inhibitory signals 
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can restore T cell functionality 119, indicating that some of these the observed alterations can 
be restored. 
There is evidence for NK cells taking part in control of HCV infection as a specific KIR-KIRL 
genotype, KIR2DL3 and homozygosity for HLA-C1/C1, strongly correlates with resolution of 
HCV infection 57. Therefor it is of interest, that HCV can interfere also with NK cell activation 
and function, either via alteration of monocyte function that in turn influences NK cells or via 
direct interaction with infected cells 121,122. Lastly, not only NK cells and CD8+ T cells are 
affected, but also other immune cells are influenced, as for example altered Treg 123 and DC 
frequencies124 have been reported. Thus, HCV infection has a profound impact on the immune 
system which makes it clear why this pathogen is so successful in establishing chronic 
infection.  
From a clinical point of view, treatment of chronic HCV has undergone a revolution in recent 
years from a hard-to-treat disease to currently a >95% cure rate 125. The newly developed drugs, 
referred to as direct acting antivirals (DAA), cure HCV within a short period of time 107,125. 
This rapid clearance makes it possible to answer questions regarding the immunology of 
hepatitis C, for example if the immune dysfunction can be restored or if an imprint on the 
immune system remains. 
1.7.3 Liver cirrhosis 
Eventually, all chronic liver diseases can lead to increased fibrosis and finally liver cirrhosis 
126. This final step of the diseased liver is thought to be irreversible and comes with high 
mortality 127. Cirrhosis itself is defined by a fibrotic reorganization with loss of regular liver 
structure, smaller size of the liver and heightened stiffness which can be diagnosed either by 
histopathology, ultrasound, or transient elastography (e.g. FibroScan®) 126,128. This stiffness 
and increased fibrosis can lead to a higher pressure in the blood flow to the liver, thus called 
portal hypertension. The higher pressure in this area can in turn lead to circumventions via 
veins that become enlarged (varices) and have a higher risk of bleeding 126. Additionally, fluid 
accumulation in the peritoneal cavity (ascites) because of portal hypertension can reach 
significant amounts and crave medical intervention 126. Depending on the presence of cirrhosis 
related complications, one speaks either of “compensated”, when otherwise asymptomatic, or 
“decompensated” cirrhosis, when complications such as liver dysfunction, ascites, or varices 
occur 127.  
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Apart from more localized effect, cirrhosis leads also to systemic perturbations. For example, 
dysfunction of the liver and its anatomical changes can lead to cirrhosis-related immune 
dysfunction 129. Thus, it is not surprising, that a significant proportion of the cirrhosis-related 
mortality is due to infections 130. In line, the combination of immune dysfunction and higher 
pressure in the portal vein and ascites, it is not surprising that bacterial translocations can occur 
from the gut to the ascites. This then leads to a severe infection of the peritoneal cavity, a so 
called spontaneous bacterial peritonitis (SBP). Not only is SBP the most frequent infection in 
cirrhosis 131, but also causes high mortality 130. If and how the immune dysfunction in patients 
















The overall aim in this work was to assess the impact of chronic infection and/or 
inflammation as well as tissue microenvironments on the shape of the human immune system 
with a focus on NK cells and MAIT cells. The specific aims addressed in each project are as 
follows: 
2.1 DEFINING THE IMPACT OF CHRONIC HCV INFECTION ON INNATE 
LYMPHOCYTES AND UNCONVENTIONAL T CELLS 
2.1.1 Analysis of MAIT cells before and after clearance of HCV (project 1) 
2.1.2 Study of the NK cell compartment and its diversity in DAA mediated 
viral clearance (project 2) 
2.2 INVESTIGATION OF THE PERITONEAL IMMUNE SYSTEM IN LIVER 
CIRRHOSIS WITH A FOCUS ON MAIT CELLS (PROJECT 3) 
2.3 ESTABLISH A MAP FOR HOW UTERINE NK CELLS DIFFERENTIATE IN 







3.1 ETHICAL CONSIDERATIONS 
Ethical evaluation must be the basis for all medical research. In each project, ethical evaluation 
took place before start of the study and ethical permissions were granted from the relevant 
ethical authorities. 
In the case of adult HCV patients, peripheral blood was sampled (Permit numbers for Project 
1 &2: 2148-2014). Healthy adults as part of control cohorts were either acquired by sampling 
peripheral blood or using buffy coats which are prepared remnants after blood donation (Project 
1&2: 2148-2014, Project 4: 2006/229-31/3). Matched peripheral blood and ascites samples 
from cirrhosis patients or peripheral blood samples for controls was used in Project 3 (permit 
number: 3188-2016). In Project 4 peripheral blood and endometrial samples were used 
(2013/1324-31/2 with 2014/1996-32 and 2016/1313-32), as well as samples from decidua 
(2012/1968-31/1 and 2017/649-31/1). Other cohorts included were endometrial samples from 
uterus transplantation (362-16 and T1052-16), monozygotic twins (2013/1324-31/2 and 
2017/193-32) as well as control samples from tonsils (2006/646-31/4, 2013/217-21, 2014-
1470-32-4 and 2015/1083-32) and liver (2013/2285-31/3). Animal experiments were 
performed after approval by the Linköping Animal Experimentation Ethics Committee 
(2015/1368-31/4, 2015/2122-32 and 29-15). 
To conclude, for all projects ethical evaluation took place, the necessary permissions for sample 
acquisition and analysis have been granted and all patients gave written consent prior to study 
inclusion.  
 
3.2 COLLECTION OF SAMPLES AND PROCESSING 
Peripheral blood samples were collected in heparin-coated tubes via venous puncture. The 
blood of each donor/patient was pooled and PBMC isolated via density-gradient 
centrifugation. After collecting the interphase containing the PBMC, the samples were 
washed and either used for experiments or frozen down at -180°C in FCS with 10% DMSO 
for long-term storage (Paper 1-3).  
Tissue samples from the uterus were subjected to mechanical dissection with scalpels before 
enzymatic digestion at 37°C with Collagenase II (Sigma) and DNase I (Sigma). After that, 
mononuclear cells (MNC) were isolate via density gradient centrifugation and frozen as 
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described above (Paper 4). Liver samples were first flushed to remove excess blood before 
being perfused with collagenase XI for enzymatic digestion and finally mononuclear cells 
were isolated and frozen as above (Paper 2 and 4). Tonsil samples were mechanically 
dissected and filtered through a 40µm mesh before being frozen as above (Paper 4). Ascites 
cells were centrifuged and subjected to red blood cell lysis before being frozen for long term 
storage (Paper 3). Menstrual blood was collected as described before 86. In brief, the donors 
collected the blood in menstrual cups before being transferred to collection medium 
containing heparin, amphotericin B and penicillin/streptomycin. The blood was then 
processed and frozen as described for peripheral blood (Paper 4). 
3.3 FLOW CYTOMETRY AND CELL SORTING 
One of the main methods in immunology is flow cytometry, or fluorescence-activated cell 
sorting (FACS). For this analysis, cells are stained with fluorochrome-conjugated antibodies, 
before being acquired on the flow cytometer. Here, the emissions of these fluorochrome-
antibody-conjugates after laser excitation are recorded and the expression of molecules can 
be analyzed.  
To this end, the either untreated cells (for ex vivo phenotyping) or stimulated cells (for 
assessment of functionality) were stained with a combination of antibodies and dead cell 
marker (eBioscience). Then, cells were fixed and, if an intracellular staining was to be 
performed, permeabilized. Intracellular staining was necessary for recording of transcription 
factors or other intracellular molecules, such as interferon-g (IFNg) and TNF.  
After acquisition, flow cytometry files were analyzed in FlowJo version 9 (Paper 1-4) and 
FlowJo version 10 (Paper 3-4). Here, experimental sets were compensated and populations 
of interest gated and marker expression analyzed. Dimensionality reducing methods such as 
stochastic neighbor embedding (SNE) and uniform manifold approximation and projection 
(UMAP) analysis were used either in R version 3.3-3.6 or as plug-in of FlowJo version 10, 
Phenograph clustering analysis was used as plug-in of FlowJo version 10. For these analyzes, 
of the populations to be investigated, the same amounts of cells were exported and barcoded 
to enable back tracing. 
In some experiments, the function or transcriptome of a specific subset of immune cells was 
of interest. Here, cells were stained without fixation and then sorted alive into the desired 




3.4 FUNCTIONAL ASSAYS  
For studies of peripheral blood NK cells, established assays to assess natural cytotoxicity, 
ADCC, and cytokine response were used. To this end, NK cells were thawed, plated and 
rested overnight. Natural cytotoxicity was investigated via six hours incubation with K562 
target cells at an effector to target of 10:1 and ADCC after incubation with 721.221 cells with 
the anti-CD20 antibody Rituximab. Response to cytokines was examined via stimulation 
overnight with IL-12 /IL-18 at 10ng/mL and 100ng/mL, respectively (Paper 2).  
Functionality of MAIT cells both in peripheral blood and in ascites was assessed both with 
stimulation via the MR1-TCR axis and cytokine response (Paper 1 and 3). For TCR 
stimulation, E. coli from the laboratory strains D21 or DH5a were fixed shortly before being 
added to plated PBMC. The cytokine stimulation of MAIT cells was performed in the same 
way as for NK cells (Paper 1 and 3).  
In all functional assays for flow cytometric analysis, Brefeldin A and Monensin 
(GolgiPlug/Stop, BD Biosciences) were added for the last 5 hours. At the end of the assay, 
cells were stained with fluorescently-labelled antibodies and fixed before acquisition on the 
flow cytometer. 
Investigation of uNK cell function (Paper 4) was either performed via generation of 
supernatants or direct stimulation for 6 hours with PMA/Ionomycin (10ng/mL and 500nM, 
respectively) for flow cytometric analysis. Supernatants were collected after stimulation with 
IL-12/IL-15/IL-18 overnight at 20ng/mL, 20ng/mL and 200ng/mL, respectively, or with 
PMA/Ionomycin as described above. Supernatants were collected after centrifugation and 
frozen at -80°C until further use. The soluble factor profile of supernatants were then 
analyzed by SciLife, Uppsala, via Proximity extension assay (PEA), a method using 
oligonucleotide-tagged antibodies for detecting up to 92 proteins simultaneously.  
Proliferation of uNK cell subsets was investigated after plating of equal numbers of CellTrace 
labelled sorted uNK cells and stimulation with IL-15 at 10ng/mL for seven days. Medium 
was replaced every other day. For in vivo differentiation assays, sorted uNK cell subsets were 
injected intravenously in MISTRG mice together with intraperitoneal IL-15 (at day 0 and day 





3.5 RNA SEQUENCING 
For investigation of the transcriptome of uNK cell subsets, the respective subsets were sorted 
into RLT buffer (Qiagen). Purification of RNA, subsequent cDNA preparation as well as 
sequencing was performed by the Bioinformatics and Expression Analysis (BEA) core 
facility, Huddinge. In brief, transcriptome data was then analyzed after quality control with 
FastQC (v0.11.5), trimming via Trim Galore! (v0.6.4) alignment to the reference Genome 
with STAR (v020201) and finally DESeq2 package (v1.22.2) for differentially expressed 
genes (DEGs). For gene set enrichment analysis (GSEA), either DEGs were compared to the 
background list with the GOrilla tool 132 or the ranked list of expressed genes was compared 
to publicly available databases 133,134 with the GSEA software tool (v4.0.1) 135,136. 
3.6 MICROSCOPY 
Imaging of uterine samples (either endometrial or decidual, paper 4) was performed sections 
from OCT embedded snap frozen samples. Expression of CD39, Eomes, CD3, and DAPI was 
visualized via Confocal Microscopy. To this end, samples were fixed, blocked to protect 
unspecific antibody binding before being incubated first with primary and then secondary 
antibodies. Imaging was performed on a Nikon A1R confocal microscopy instrument and 
images analyzed with the Imaris software.  
3.7 STATISTICS 
Data was analyzed in Graphpad Prism versions 6-8. In a first step data was tested for normal 
distribution. If not-normally distributed, either a Wilcoxon, Mann-Whitney, Friedman’s or 
Kruskal-Wallis test or Spearman correlation were performed, depending on number of 
sample groups and if paired samples should be compared. In case of normal distribution, 
either paired/unpaired t-test, or Pearson correlation were chosen. Fisher’s exact test was used 
for contingency tables.  
3.8 ADDITIONAL RESOURCES 
Further analysis, such as principal component analysis (PCA), were performed in R (versions 




4 RESULTS AND DISCUSSION 
4.1 THE IMPACT OF CHRONIC HCV INFECTION ON THE IMMUNE SYSTEM 
Chronic infection with HCV leads to severe alterations in the immune system 108. In T cells, it 
has been well described that chronic HCV infection can cause immune exhaustion. These 
HCV specific and exhausted T cells display elevated expression of inhibitory receptors, such 
as PD-1, reduced proliferative capacity, and weak cytokine response to antigen stimulation115-
117. In the innate immune system, NK cells have been shown to be important in spontaneous 
resolution of HCV infection 57 but to be dysfunctional in chronic disease 137,138. Thus, HCV is 
able to evade the immune system by suppressing and altering its functionality at different 
levels. The recent approval of DAA for the treatment of HCV has drastically improved its 
prognosis and HCV can now be cured within a short period of time 125. This allows to study 
the immune system in HCV in a dynamic setting where the chronic infection is rapidly 
removed and one can investigate if immune dysfunction can be restored or if it there is a 
lasting effect. Thus, in collaboration with the medical university of Hannover, patient and 
control samples were collected and studied for MAIT and NK cell phenotype and function 
before, during and after viral clearance (Paper 1 and 2).  
4.1.1 MAIT cell frequencies are reduced in chronic HCV infection 
It has been shown that MAIT cells can be activated in viral infections 25,36, but that their 
abundance in peripheral blood during these infections is significantly diminished, as for 
example in chronic HIV 31. Therefore, we set out to investigate MAIT cells in the setting of 
chronic HCV infection and subsequent viral clearance upon DAA treatment (Paper 1). In 
order to get a broader picture of the immune system, we first determined the percentages of 
26 immune cell populations in peripheral blood of chronic HCV-patients and healthy controls 
(Paper 1, Figure 1). In comparison to healthy controls, we observed alterations that have 
been described before, such as elevation of memory T cells 139 and Treg 123. Yet, the most 
pronounced change was a loss of MAIT cells in periphery from an average of 3.4% of T 
cells in healthy controls to 0.6% in HCV patients. Of note, this loss was confined to MAIT 
cells, as the T cell population expressing TCRVa7.2 but lacking CD161 displayed similar 
percentages in patients as in healthy controls. To see if the loss of MAIT cells could be 
linked to other alterations in the immune system, we correlated the percentages of the 
respective immune cell populations. Here, we found no significant correlations between 
MAIT cells and other immune cell types, indicating that this is a more isolated effect of 
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chronic HCV on the MAIT cell population. Altogether, we noted a significant reduction of 
MAIT cells in chronic HCV. 
4.1.2 Persistent reduction of MAIT cell abundance and continioued 
dysfunction upon HCV clearance 
As the noted loss of MAIT cells represents the state of chronic infection before initiation of 
antiviral therapy, it was of interest to investigate if this impact of HCV infection on the 
immune system could be restored after viral clearance. It has been shown that reduced MAIT 
cell frequencies are reversible in certain conditions, for example as the loss of MAIT cells in 
obese patients can be reversed after bariatric surgery and ensuing weight loss 33. Furthermore, 
it has been reported that T cell dysfunction in HCV to some extent is restored after treatment 
with DAA and viral clearance 140. Thus, it could be speculated that also MAIT cell alterations 
are reversible upon elimination of the chronic insult. Here, we first investigated the dynamics 
of viral clearance in our patient cohort and could recapitulate the previously observed rapid 
drop of HCV RNA levels during DAA treatment 125,141 (Paper 1, Figure 2). Of interest, 
despite this rapid resolution of HCV infection, MAIT cell numbers remained unaltered, even 
up to 72 weeks after start of treatment. Looking at the phenotype of MAIT cells in chronic 
HCV infection, we observed an activated phenotype with elevated expression of granzyme B, 
CD69, HLA-DR, and PD-1. In line with the persistent reduction in MAIT cell frequencies, 
we noted only a partial restoration of the MAIT cell phenotype with prolonged elevated 
levels of activation markers. 
Given the altered abundance and phenotype of MAIT cells, we next studied if also the 
functionality of MAIT cells was altered in chronic HCV infection (Paper 1, Figure 3). Upon 
stimulation with E. coli, MAIT cells from HCV patients displayed lower levels of granzyme 
B, TNF and IFNg production and reduced degranulation (indicated by CD107a). In 
agreement with the observed persistence with respect to changes in frequency and phenotype, 
this observed dysfunction was not restored after viral clearance. Looking at cytokine priming 
of MAIT cells, surprisingly no changes in MAIT cell function could be observed in chronic 
infection. Thus, only TCR-dependent stimulation appeared permanently affected in MAIT 
cells while their ability to respond to cytokines was not. Lastly, also on the transcription 
factor level, alterations were noted. MAIT cells from HCV-patients expressed less PLZF, a 
main driver of effector functions 142. Even though we could not determine a direct correlation 
between PLZF and MAIT cell function, the lower expression levels might be relevant for the 
noted dysfunction.  
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Concluding, despite rapid viral clearance after DAA treatment we found persistently reduced 
MAIT cell frequency and irreversible dysfunction in remaining MAIT cells in chronic HCV. 
A limitation of our study is the fact that we analyzed MAIT cells only from peripheral blood 
and not the liver, yet more recent studies could recapitulate our findings in peripheral blood 
and also in intrahepatic MAIT cells 143,144. Furthermore, similar patterns had been observed in 
chronic HIV infection, where MAIT cell numbers remained reduced and their phenotype and 
function partially restored, even if patients were und antiviral treatment and virus replication 
suppressed 21. The reason for this loss in MAIT cells is not yet known. It might be the 
constant stimulation in chronic infections that is driving increased MAIT cell turnover, as 
increased apoptosis has been observed upon IL-18 treatment 145. Also a redistribution from 
the blood to other tissues could be an underlying reason, even though this is less likely 
given the findings of persistent loss of MAIT cells also in the liver 144. Thus, future research 
examining these mechanisms is warranted. Notably, also the implications of this persistent 
loss of MAIT cells are still uncertain. It can be hypothesized that this comes along with a 
weakened defense against pathogens, but also here further studies are wanted.  
4.1.3 NK cells in chronic HCV 
As described above, NK cells are thought to take part in controlling the HCV infection. Yet, 
once the chronic infection is established, NK cells are dysfunctional and display a skewed 
phenotype 138. If one assesses NK cells not as one uniform population, but instead as different 
subpopulations with distinct functionalities, as for example the differences between CD56bright 
and CD56dim 41, the NK cell compartment becomes a diverse compartment with many 
subgroups 146. Such NK cell diversity has been investigated in HIV infection, where in 
contrast to CD4 and CD8 T cells, only differences in NK cell diversity could be associated 
with chronic HIV infection 147. In Paper 2 we therefor investigated NK cell compartment and 
its diversity before, during, and after DAA-mediated clearance of HCV. In this study, the 
main cohort consisted of 26 patients with advanced fibrosis/cirrhosis that were treated with 
Sofosbuvir/Ribavirin and followed until week 36 after start of treatment; eight of these 
patients experienced a relapse after end of treatment (Paper 2, Supplementary table 1). 
Additionally, two cohorts with long term follow-up until week 120 were included for 
assessing long-term effect and influence of level of fibrosis: one cohort of nine patients with, 
and a second cohort of twelve patients without advanced fibrosis/cirrhosis at the start of 
treatment (Paper 2, Supplementary table 2). 
 
22 
4.1.4 Altered phenotype and NK cell diversity in HCV patients 
To start with, we compared first the phenotype of CD56bright and CD56dim NK cell from HCV 
infected patients before treatment to healthy controls, both with SNE and single parameter 
analysis (Paper 2, Figure 2 and Supplementary Figure 1). While many of the investigated 
markers remained unchanged, we could observe an effect on NK cells marked by lower 
expression of activation markers such as NKG2D and NKp46. SNE analysis also showed that 
these NK cells were in clusters with a similar pattern with lower levels of activation receptors 
that were more frequent in HCV patients, as highlighted by residual plots displaying the 
subtracted density plot of patients and controls.  
Next, we validated our measures of both intra- and inter-individual NK cell diversity on a 
cohort of healthy donors stratified for CMV and Epstein-Barr-virus (EBV) infection as well 
as on NK cells from liver tissue before applying them on our HCV cohort (Paper 2, Figure 3 
and 4). To this end, we calculated the diversity between individuals as standard deviation of 
the normalized marker expression (donor-to-donor expression variation, DEV) in relation to a 
previously reported cellular expression variation 148; intraindividual NK cell diversity was 
calculated with the inverse Simpson diversity index (SDI) 146 based on differentiation 
subpopulations of CD56bright and CD56dim NK cells as well as expression of NKG2A, CD57 
and KIR 62. CMV infection leads in some individuals to persistent expansions of NK cell 
with a phenotype often marked by expression of NKG2C 67. In line, independently of EBV 
serostatus, we observed in CMV positive individuals an increase in interindividual diversity 
for NKG2C and a significantly reduced SDI (Paper 2, Figure 3). Furthermore, intrahepatic 
NK cells, that exhibit in majority a CD56bright and CD16- phenotype 96, displayed reduced 
SDI but unaltered DEV.  
After this validation step we next implemented these measures to compare healthy controls 
and chronic HCV patients (Figure 4). Indeed, both for both intra- and inter-individual 
diversity, significant alterations were observed in patients. The DEV was for almost all 
evaluated surface receptors elevated, whereas SDI was significantly decreased in chronic 
HCV infection. This means that while the NK cell compartment between patients was rather 
different, within each individual it showed a lower diversity. In contrast, acute HCV infection 
did not lead to such alterations within NK cells (Paper 2, Supplementary Figure 2), 
indicating that the chronic inflammation might be of importance. 
Given the profound impact CMV infection can have on the NK cell compartment, we 
accordingly stratified phenotype, DEV, and SDI of HCV patients for CMV and other clinical 
parameters (sex, age, level of fibrosis and clinical outcome, Paper 2, Figure 5, 
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Supplementary Figure 3 and 4). Notably, none of these parameters displayed a relevant 
influence on NK cell phenotype, neither in PCA, SNE, or single parameter analysis. In line 
with this, neither CMV serostatus nor any other variable resulted in different levels of SDI. In 
contrast to this, only the degree of fibrosis led to significantly elevated DEV. We also 
investigated if altered diversity could be linked to the respective KIR and KIRL genotype, but 
only lower DEV appeared to be associated the KIRL/KIR combination C1/C1 KIR2DL3 
(Paper 2, Supplementary Figure 3).  
To assess whether the observed phenotypical alterations also had functional consequences, 
we subjected NK cells to stimulation with either K562 cells, 721.221 cells combined with 
Rituximab or IL-12/-18 stimulation (Paper 2, Figure 6). Here, we could not detect 
measurable differences when compared to healthy controls, neither in single cytokine 
expression nor in multifunctionality of NK cells. In contrast, NK cells from patients with 
milder liver disease (LDV/SOF) displayed somewhat enhanced functionality (Paper 2, 
Supplementary Figure 5). Furthermore, in patients with low intra-individual diversity 
previously reported defects in cytokine production 149 could be observed (Paper 2, 
Supplementary Figure 2 and 5). Altogether, we could not entirely recapitulate previous 
reported alterations in multifunctionality and degranulation 138,149,150. For this either different 
patient characteristics might be responsible (for example the presence of advanced liver 
fibrosis in the majority of the here included patients) or also differing methodological 
approaches that might yield varying results (IL-12/-IL-21 149 or IL-12/-15 treatment 150 versus 
the here used IL-12/-18 stimulation). 
4.1.5 The NK cell compartment during and after viral clearance 
Having shown that NK cell diversity is impacted by chronic infection with HCV, we next set 
out to investigate this in the context of rapid viral clearance (Paper 2, Figure 7). 
Remarkably, despite the rapid suppression of HCV, only discrete changes in the NK cell 
phenotype could be noted. Both expression levels and frequencies of most markers 
underwent only slight or no changes which could also be visualized by SNE analysis of the 
comparison between baseline and follow-up samples. Along the same lines, also NK cell 
diversity remained stable in the week 36 follow-up. Next, we assessed if restoration could be 
noted at the long-term follow-up in the additional two cohorts. Here, we could observe a 
partial restoration of the phenotype, as we noted a normalization of for example NKG2D and 
granzyme B up until week 120. In addition, we noted a reduction of DEV during the study 
period that we did not observe in the original cohort. This was contrasted by the SDI of the 
NK cell compartment, that did not reverse in the long-term follow-up and remained on the 
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comparable level. Furthermore, the function of NK cells throughout and after treatment 
appeared to be altered mainly during therapy (Paper 2, Figure 8) and here, mainly cytokine 
production of CD56dim NK cells was modulated.  
To conclude, we were able to show an impact of the chronic infection with HCV on different 
levels of the NK cell compartment and its diversity. Of interest, there is conflicting literature 
on the observed alterations of NK cells in HCV patients, as for example NKG2D has been 
reported decreased 121, unaltered 150,151and also elevated 149. Some of these differences can be 
explained by either clinical inclusion criteria or flow cytometry analysis. Yet, we here show a 
higher inter-individual diversity in HCV patients indicating that HCV is able to drive not one 
specific but rather varying phenotypes. The NK cell population displayed remarkable 
stability, despite rapid elimination of HCV. The observed reduction in DEV in the long-term 
cohort might be associated to an improvement of liver function 152, given that in patients with 
more advanced liver disease a higher DEV was noted. In contrast, SDI and phenotype 
remained largely unchanged. Epigenetic modifications of NK cells have been reported in 
CMV infections 70, thus similar mechanism could also be responsible for the long-term 
effects we observed. Yet it has to be noted, that other studies could show a certain restoration 
of NK cell phenotype and function after DAA treatment150,153. However, these studies had no 
or only short follow-up after treatment, whereas we investigated NK cells from patients up 
until week 120 after viral clearance. Therefor it could be that some of the reported effects are 
only of short duration mediated by the treatment itself. On the other hand, also in our setting 
NK cell restoration might occur at even later time-points.  
 
4.1.6 Conclusions and outlook 
The availability of highly potent drugs against HCV revolutionized the treatment of this 
previously hard-to-treat chronic viral disease. For studying the underlying immunology of 
chronic viral infections and the immune system’s role in viral control, this setting of rapid 
viral clearance is of great interest. Accordingly, diverse immune cells and also the cytokine 
profile have been studied in recent years before and after cure from HCV. The overall image 
to this day is that some functions and properties of the immune system appear to normalize, 
whereas others do not, as summarized in Figure 1. The imprint by chronic HCV can be 
exemplified by the study of Hengst et al. on soluble immune factors 154. Here, the cytokine 
and chemokine profile of HCV patients was investigated in the context of DAA treatment and 
HCV cure. In brief, it could be shown that some, but not all soluble markers normalize and 
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others show only partial normalization. Further studies reported similar patterns of partial 
restoration of the soluble immune compartment 155,156. Along the same lines, in CD8 T cells 
some reversal of dysfunction after viral clearance has been described 140 but also continued 
metabolic impairment 157 and persistence of HCV-specific PD-1+ CD127+ T cells158 was 
reported. In gdT cells, an altered CD38 expression was noted before treatment in some 
patients 159, but also a stable gdT cell TCR repertoire until follow-up has been described160. 
We and others reported a persistent loss and dysfunction of MAIT cells143,144,161, and lastly 
unchanged frequencies of Treg after successful treatment have been described162. Thus, it 
might be that also the differing results regarding the NK cell compartment have to be seen in 
this light, that some NK cell functions and properties restore150,153 but not all, as we report in 
paper 2 163. One also has to have in mind, that despite viral clearance many of the patients 
are not immediately to be regarded as healthy: many might still have severe liver disease as 
consequence of the long-lasting infection, that only partially and slowly recovers 152. This 
then leads to the question of how the persistent imprints on the immune system will influence 
the now cured patient’s health. In regard of the high risk of complications from advanced 




Figure 1. Changes in the immune system after rapid DAA mediated HCV cure. Colour-
coded in middle row are the outcomes of the respective alteration after treatment (red = 
persistent alteration, green = normalization). 
4.2 CIRRHOSIS, ASCITES AND LOCAL IMMUNE CELLS 
In the case of liver cirrhosis and hepatic dysfunction, ascites is a common clinical 
presentation meaning accumulation of fluid in the peritoneal cavity. This is not only a cause 
of discomfort for patients, but also a threat as bacterial entry in ascites can lead to severe and 
life-threatening infections (SBP)131. In paper 3 we therefor investigated the immune system 
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in ascites, with a focus on MAIT cells given their abundance in the liver 27 and their capacity 
to recognize bacterial metabolites 22. To this end, healthy controls, patients with compensated 
and decompensated cirrhosis were included, as well as patients with diagnosed SBP. The 
underlying etiology for cirrhosis in these patients was either viral hepatitis (both HCV and 
HBV/HDV, abbreviated as HXV) or alcohol related cirrhosis (ARC). From patients with 
decompensated cirrhosis, matched ascites and peripheral blood samples were analyzed with 
flow cytometry and multiplexing of cytokines, from compensated cirrhosis and controls only 
peripheral blood samples. 
4.2.1 Reduced frequency and activated phenotype of MAIT cells in cirrhotic 
patients 
As a starting point we first investigated MAIT cells in peripheral blood of cirrhotic patients 
(Paper 3, figure 1). In line with previous reports 164, we observed reduced frequencies and an 
activated phenotype of MAIT cells in patients, indicated by elevated expression of HLA-DR, 
Ki-67, CD25, and CD38. However, we could not observe an altered function between 
patients and controls. When stratifying for complications (compensated/decompensated 
cirrhosis) and etiology, some differences could be observed, such as higher PD-1 expression 
in HXV- than ARC-related cirrhosis, whereas other alterations, such as elevated HLA-DR 
expression were common among all patients (Paper 3, Supplementary figure 2). 
Furthermore, we could detect higher levels of markers for monocyte or macrophage 
activation and indirect signs of bacterial translocation with elevated soluble CD14 (sCD14) 
and soluble CD163 (sCD163) in patients with liver cirrhosis 145,165,166. When testing for a 
relation between liver disease, signs for bacterial translocation, and MAIT cells, we noted an 
inverse correlation between the frequency of MAIT cells and the severity of liver disease 
(indicated by Fibroscan and MELD score), as well as between frequency of MAIT cells and 
levels of sCD14 and sCD163. Altogether, these data indicate that a more advanced liver 
disease might associate with a higher risk for bacterial translocation/monocyte activation due 
to portal hypertension 167 and subsequent activation of MAIT cells 168. The loss of MAIT 
cells in periphery could then be attributed either to lower production, continuous consumption 
or recruitment to local sites. Therefor it was of interest to next study the immune 
compartment within ascites.  
4.2.2 MAIT cells are enriched, activated and functional in ascites 
To get a broader picture of the immune profile in ascites, we performed flow cytometry on 
major immune cell subsets as well as screening of cytokine levels (Paper 3, Figure 2 and 3). 
Of note, the most prominently enriched cell type were CD14+CD16+ monocytes which could 
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be seen both in frequency and UMAP analysis. Given their expression of CD163 as well as 
greater size and granularity, these cells most likely represent peritoneal macrophages, that 
also under physiological conditions reside in the peritoneal cavity 169. Looking at MAIT cells, 
also these were more frequent in ascites than in peripheral blood. Related to this, also within 
the cytokine milieu, a MAIT cell supportive composition was noted in ascites, with higher 
IL-7, a key cytokine for MAIT cell survival and functionality 21,170, as well as lower IL-18, 
able to activate but also induce apoptosis of MAIT cells 145. 
Studying the phenotype of peritoneal MAIT cells in more detail, we could observe an 
enrichment of mainly CD8+ MAIT cells within the ascites (Paper 3, Figure 3). Furthermore, 
UMAP and Phenograph analysis revealed specific clusters that were more frequently present 
in ascites than in blood (Paper 3, Figure 3 and 4). These were marked by expression of the 
tissue residency markers CD69, CD103, and CD49a 171. This suggests that tissue resident 
MAIT cells from the liver or intestine either get actively recruited to the ascites or leave these 
tissues due to increased venous and interstitial pressure in the portal drainage area. 
Interestingly, we could also observe higher levels of CXCR3 and CXCR4 on peritoneal 
MAIT cells (Paper 3, Supplementary figure 4), which in combination with elevated 
CXCL10 and peritoneal mesothelial cell derived CXCL12 172, respectively, could lead to 
increased transition of MAIT cells from blood to ascites. 
Next, we analyzed peritoneal MAIT cells in relation to the etiology of cirrhosis. Here, we 
noted minor phenotypic differences and, interestingly, a significantly reduced frequency of 
peritoneal MAIT cells in HXV patients compared to ARC, a pattern that was not seen in 
peripheral blood (Paper 3, Figure 3 and Supplementary figure 2). It has been reported that 
the intrahepatic loss of MAIT cells in HCV is correlated to the degree of liver fibrosis and 
that the reduced abundance persists even after initiated DAA treatment 144. Yet, the here 
studied cohorts of HXV and ARC patients displayed a comparable degree of liver disease. 
This might indicate that tissue-resident MAIT cells are reduced to a greater extent in HXV 
than in ARC, resulting in fewer MAIT cells that can be recruited to the ascites. However, 
further studies are needed to address this question in detail. 
Finally, we studied how the functional capacities of peritoneal MAIT cells were influenced 
by the local milieu (Paper 3, Figure 4). Interestingly, both upon E. coli stimulation as well as 
cytokine priming, peritoneal MAIT cells presented with elevated functionality, seen as higher 
levels of IFNg and granzyme B produced in response to both stimulations and TNF upon 
TCR-dependent stimulation. We also noted an inverse correlation between IL-18 levels in 
ascites and MAIT cell functionality. While IL-18 can activate MAIT cells, it might be that a 
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chronic stimulation leads to a certain dysfunction and apoptosis 145. Given the abundance of 
peritoneal macrophages in ascites, we also tested whether these would influence local MAIT 
cell function but could not detect significant differences (Paper 3, Supplementary figure 6). 
4.2.3 Enrichment of MAIT cells in spontaneous bacterial peritonitis 
Given the increased abundance of MAIT cells and ascites and their ability to respond to 
bacterial infection, it was of interest to study peritoneal MAIT cells in SBP (Paper 3, Figure 
5). Notably, in this condition, MAIT cells were even further enriched in ascites, both in 
relative abundance and in absolute numbers. Moreover, when looking at all immune cells 
comparing SBP to non-SBP, MAIT cells were the most enriched immune cell subset. Next, 
we investigated if differences could be noted in their phenotype and in the cytokine milieu. 
Yet, both regarding MAIT cell phenotype and the cytokine profile we observed surprisingly 
few differences between SBP and non-SBP. One of the cytokines that was most strongly 
reduced was IL-7, which appears to be in contrast to the elevated MAIT cell frequency. On 
the other hand, CCL5 was increased in ascites from SBP patients and can bind to CCR5, 
which is highly expressed on circulating MAIT cells 24. As also tissue resident phenotypes 
were slightly more prevalent in non-SBP patients, this could indicate an enhanced recruitment 
of MAIT cells to ascites from circulation during SBP. 
4.2.4 Summary and future studies 
Liver disease is frequent and cirrhosis a severe condition with strongly increased mortality 
127. A frequent complication of cirrhosis is ascites and connected to this also SBP 130,131. Here 
we performed a comprehensive analysis of the immune system located to ascites of patients 
with or without SBP. We could show an enrichment of MAIT cells in the ascites, that these 
cells display an activated phenotype, and that they are highly functional. This is of interest, as 
in many other chronic conditions, MAIT cell frequency and functionality was found to be 
reduced 31,34,161. One explanation for the elevated frequency and function of peritoneal MAIT 
cells might be the local cytokine milieu that is supporting MAIT cells, as for example IL-7 
was present at higher levels. Additionally, peritoneal MAIT cells appeared to be recruited to 
some extent from tissue, as shown by the elevated expression of tissue residency markers. 
This could be mediated by the chemokine receptor expression on MAIT cells (high levels of 
CXCR3 and CXCR4) and the cytokines present in the peritoneal cavity (CXCL10 and 
CXCL12) 172. Given their ability to respond readily with innate effector functions, MAIT 
cells present an interesting target for possible interventions and treatments in bacterial 
infections 173. Thus, future studies should evaluate if and how MAIT cell modulation is 
possible in these conditions. Also, an outstanding question for future investigations is if the 
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loss of MAIT cells in cirrhosis in peripheral blood already might predispose to bacterial 
infection. 
4.3 TISSUE RESIDENT NK CELLS IN THE UTERUS 
The uterus has a unique composition of immune cells. In contrast to peripheral blood, the 
relative abundance of residing immune cells is shifted away from T cells towards NK cells 
and monocytes/macrophages 64,174. The underlying theory is that this shift together with other 
mechanisms, as for example higher levels of local Treg 175, aims to prevent T cell 
allorecognition of the fetus. In this context it is of interest, that especially NK cells are found 
at higher frequency and with a unique phenotype of co-expression of NKG2A and KIR on 
CD56bright NK cells, that is not present in peripheral blood 84. Recent advances in single-cell 
transcriptomics revealed even an even greater heterogeneity with the existence of a subgroup 
of NK cells expressing CD39 176. This is of interest, as CD39 is known to be expressed by 
Treg and that it mediates immune suppressive effects via cleavage of extracellular ATP 177. 
Thus, it is intriguing if uNK cells possibly could have such a function, too. Yet, it remains 
unclear how this immune composition and NK cell phenotype can be upheld in regard to the 
continuously regenerating endometrium that is shed each month during menstruation. To 
investigate this, we performed study 4, and assessed uterine NK cell differentiation and 
function in the regenerating endometrium and in pregnancy. 
4.3.1 Uterine NK cells are distinct in blood, endometrium and decidua and 
comprise three main subsets 
As a starting point, we set out to determine the global phenotypic profile of uNK cells in 
endometrium, decidua, and peripheral blood (Paper 4, Figure 1). To this end we barcoded 
cells from three donors from each tissue and screened the surface proteome with the 
LegendScreen (Biolegend). We validated our data by detecting previously reported markers 
of uNK cells that are expressed both in endometrium and decidua, such as KIR, CD9, and 
CD49a 84,86. Notably, we also uncovered novel molecules uniformly expressed on uNK cells, 
among others GITR, CD82, and Sialyl Lewis X. Additionally we could discriminate patterns 
more prevalent in either decidua or endometrium, as seen in hierarchical clustering, PCA, and 
single parameter analysis. Here, activating receptors (such as NKG2D, NKp46 and NKp30) 
were expressed more frequently on decidual uNK cells whereas cytokine and chemokine 
receptors where elevated on endometrial uNK cells (IL-21R, CXCR7).  
Having outlined the global pattern and differences, we then investigated it in more detail in 
the context of NK cell differentiation (Paper 4, Figure 2). The acquisition of KIRs is tightly 
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linked to differentiation of peripheral blood NK cells 62. Therefore, we investigated the 
surface proteome in KIR- and KIR+ uNK cells and could identify distinct patterns, among 
which we also detected the previously reported CD39 nearly exclusively expressed on KIR+ 
uNK cells. Further stratification to the three distinct subsets of KIR-CD39-, KIR+CD39- and 
KIR+CD39+ uNK cells suggested a step-wise model of receptor acquisition. In addition, we 
could observe both higher expression levels of KIRs and more KIRs simultaneously co-
expressed per cell. Together, these data suggest that, equivalent to peripheral blood 
differentiation, uNK cells differentiate from KIR-CD39- over KIR+CD39- to KIR+CD39+ 
cells. Moreover, we could underline these findings with additional results. Data from RNA 
sequencing of the three subsets and from CyTOF analysis confirmed that uNK cells aligned 
along this hypothesized differentiational pathway in PCA and Wishbone trajectory analysis, 
respectively. Finally, we also re-analyzed published single-cell RNAseq data 176with 
Pseudotime analysis (SlingShot), a method used for displaying continuous changes (as in 
differentiation) in single cell transcriptomic data. Also in this analysis, we could recapitulate 
a subsequent acquisition of KIR and finally CD39, that was accompanied by altered marker 
expression. Linking this data together, we found consistent phenotypic alterations across 
several of our datasets including loss of CD27, CD11c and CXCR4, and upregulation of KIR, 
CD39, and LILRB1. 
4.3.2 uNK cell differentiation is coupled to endometrial regeneration and 
pregnancy 
After having defined a possible differentiational axis of uNK cells, we then set out to analyze 
this pathway throughout the menstrual cycle. To this end, we collected samples from ten 
healthy women during the proliferative and secretory phase (using endometrial biopsies), as 
well as menstrual blood (representing the end of the cycle). First, we assessed the immune 
cell distribution and the respective subset proliferation throughout the cycle. Strikingly, uNK 
cells peaked in proliferation during the later phase of the cycle. When analyzing the outlined 
uNK cell subsets throughout the cycle as well as in early pregnancy (decidua) and in 
postmenopause (PMP), we saw an increase of the relative abundance of KIR+CD39+ uNK 
cells in menstrual blood and thus after the peak in proliferation. This level was then also seen 
in pregnancy, whereas nearly no NK cells with a uNK cell phenotype could be observed in 
PMP. This indicates that sex hormones play a crucial role in shaping the endometrial immune 
compartment and that it is continuously changing. 
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4.3.3 The regulation and tissue residency of KIR+CD39+ uNK cells. 
In the analyses this far, we noted a pronounced variation in the relative abundance of 
KIR+CD39+ uNK cells. It has been shown, that CD39 is one of the molecules with a high 
genetic inheritance on Treg 178. Therefor we set out to study the frequency of uNK cell subsets 
in monozygotic twins. Here we noted a high concordance among each twin pair, indicating 
that also on uNK cells a genetic component might be of importance. Yet, as the endometrium 
is shed each month, we were intrigued to study further if and how this tissue resident 
population could be generated. There have been studies supporting the two concepts of either 
local repopulation or recruitment from periphery. On the one hand, resident CD34+ 
progenitors have been described that might give rise to a local population 179, as well as data 
from parabiosis experiments in mice, showing a tissue resident uNK cell population 180. On 
the other hand, an inducible uNK cell phenotype 181and recruitment from peripheral blood 
was suggested 182. We had the chance to study endometrial samples from HLA-mismatched 
uterus transplanted patients to investigate the origin of uNK cells according to their HLA-
type. Indeed, in the cases investigated we could identify bona fidae uNK cells that appeared 
to be from recipient origin, suggesting a recruitment from periphery. 
4.3.4 IL-15 drives uNK cell differentiation in vitro and in vivo 
Given the observed dynamics of uNK cell subsets throughout the menstrual cycle, a likely 
link between endometrial regeneration and uNK cell differentiation is the previously 
described progesterone-mediated production of IL-15 by stromal cells 183,184. Therefor we 
tested the differentiation and proliferation of sorted uNK cell subsets both in vitro and in vivo 
(Paper 4, Figure 4). Indeed, resembling the pattern of peripheral blood NK cell 
differentiation 62, the ability to proliferate was continuously lost from KIR-CD39- over 
KIR+CD39- to KIR+CD39+ uNK cells. Furthermore, we noted upregulation of CD39 almost 
exclusively on proliferating cells. Similarly, after injection of sorted uNK cells in MISTRG 
mice 185,186, upregulation of KIR and CD39 or only CD39 was seen on KIR-CD39- or 
KIR+CD39- uNK cells, respectively. Altogether, this would suggest that uNK cells 
differentiate in response to IL-15. 
4.3.5 Differentiation of uNK cells is linked to altered functionality and 
reduced inflammatory pattern 
A hallmark of lymphocyte differentiation is that it is coupled to modified functionality.  
Therefor we next studied possible alterations also during uNK cell differentiation. As uNK 
cells are known to be weakly cytotoxic 64, we first aimed to investigate the profile of released 
soluble factors by the respective subsets. To this end, we analyzed supernatants after 
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stimulation with PEA and measured 92 soluble markers (Paper 4, Figure 5). Indeed, we 
observed a shift from more pro-inflammatory cytokines, such as IFNg, CCL4, and TNF 
produced by KIR-CD39- uNK cells, towards more immuno-modulatory factors like galectin-1 
and -9 more highly produced by KIR+CD39+ uNK cells. The latter factors have been 
proposed to be involved in modulating T cell immunity 187,188, and thus suggesting an 
immune-modulatory role of KIR+CD39+ uNK cells. Looking at the differential profile of 
immune factor production, we noted, in line with the observations in the surface proteome, 
that the KIR+CD39- subsets appeared to represent an intermediate state between KIR-CD39- 
and KIR+CD39+.  
We then went on to confirm these findings with flow cytometry. As expected, we could 
observe the distinct reduction of pro-inflammatory cytokines in KIR+CD39+ uNK cells. Of 
note, these cells were able to degranulate more and had higher levels of perforin, which is in 
line with previous work showing higher granule content in KIR-expressing uNK cells 189. 
Concluding, we noted a skewing of uNK cell functionality away from pro-inflammatory 
markers to possibly immune modulating markers. 
4.3.6 Conclusion and perspectives 
Despite advances in research, many issues in the immunology of the uterus and pregnancy 
remain unsolved. Here, we aimed to address the question of how the locally residing immune 
cells respond to and keep up with the repetitive regeneration of the human endometrium and 
its transformation to decidual tissue. We present a possible pathway of differentiation 
originating from KIR-CD39- uNK cells over acquisition of first KIR and then CD39 to 
KIR+CD39+ cells. Furthermore, we could link this differentiation to the menstrual cycle and 
propose progesterone induced IL-15 as main driver of this process 184,190. Along this proposed 
differentiational axis we noted a shift in uNK cell function away pro-inflammatory cytokines 
that were mainly produced by KIR-CD39- uNK cells, towards more immuno-modulatory, 
such as galectin-1 and -9 187,188. The latter have also been associated with angiogenic 
properties 191. Thus, it might be plausible that the late rise of KIR+CD39+ uNK cells is of 
importance especially during the early phase of pregnancy, given their late appearance in the 
cycle and their functional properties. Furthermore, CD39 itself might contribute locally to a 
more immunosuppressive environment, especially when in contact with CD73-expressing 
trophoblast 176. The two ectoenzymes CD39 and CD73 work in concert to cleave extracellular 
ATP into adenosine, which in turn has immunosuppressive effects 192. Hence, the 
combination of skewed functionality and increased levels of extracellular adenosine might 
contribute to the local immunological milieu needed for the establishment of a pregnancy. 
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However, we noted a significant variation among individuals with KIR+CD39+ uNK cells 
representing all from 4% to 64% of the uNK cell population. As these cells express high 
levels of KIR and as associations between KIR/KIRL genotypes and pregnancy associated 
pathologies have been reported 87,88, this variation is of great interest and should be 

























5 CONCLUDING REMARKS 
The immune system is involved in the control of infections and tissue function. To this end, 
MAIT cells and NK cells are present at different sites and display at each a particular 
phenotype and functionality. In chronic infections, these can be severely altered but little is 
known if and how imprints remain after clearance of the chronic insult. Here, we studied 
MAIT and NK cell function in different settings of tissue homeostasis, tissue pathology as 
well as during and after cure of a chronic viral infection. Below, key findings of each study 
are listed: 
- MAIT cell frequency is reduced in chronic HCV patients and the remaining cells are 
dysfunctional (Paper 1) 
- The altered frequency, phenotype, and function of MAIT cells persist after rapid 
clearance of chronic HCV infection (Paper 1) 
- In patients with chronic HCV, NK cell phenotype and diversity are altered (Paper 2) 
- Only partial restoration of the NK cell phenotype occurs upon rapid HCV cure 
(Paper 2) 
- Intraindividual NK cell diversity (SDI) is not altered after clearance of HCV, whereas 
interindividual diversity (DEV) improves in association with amelioration of liver 
disease (Paper 2) 
- MAIT cells are more frequent, express tissue residency markers and display elevated 
functionality in the ascites of cirrhotic patients (Paper 3) 
- Upon SBP, peritoneal MAIT cells are further enriched compared to non-SBP patients 
(Paper 3) 
- uNK cells display a specific surface proteome distinct from peripheral blood (Paper 
4) 
- Differentiation of uNK cells is linked to the menstrual cycle and KIR+CD39+ uNK 
cells arise late in the cycle and in pregnancy (Paper 4) 
- Functional skewing of KIR+CD39+ uNK cells away from pro-inflammatory 












My past years at CIM I have met and worked with many great people, without you all this 
thesis would not have been possible. Thank you all so much! 
First, my main supervisor, Niklas, thank you for accepting me as PhD student and for guiding 
me through these years. It has been a great time and I learnt a lot; you gave me freedom to 
explore and we still always found the way back when I was lost in too many interesting 
findings. Thank you also for staying positive whenever it felt like nothing is working out. I 
am so grateful for this inspiring time that pushed my enthusiasm for research! 
My co-supervisors: Hans-Gustaf, thank you for introducing me to CIM and to Niklas, for the 
inspiring input to my projects and for the discussions on future steps!  
Heiner thank you so much for the fruitful collaboration! It was a great pleasure to work with 
you and your group. It was truly inspiring to see how you manage to combine clinics and 
research. Thank you for hosting us in Germany and for always taking time to discuss results 
when in Stockholm. I am grateful to have had you as my co-supervisor!  
Johan, thank you for the collaborations, for introducing me to the fascinating field of MAIT 
cells and for your support!  
All former and present NB group members! It has been and still is great fun to work with 
you all. Christine, for your enthusiasm and your positivity – I hope you enjoy post-PhD life 
J Natalie, for our shared joy of statistics and all chats throughout the years; Otto, for all the 
fun talks when I finally understood your NZ accent – hope you are well! Martin I, for 
introducing me to uterine immunology and the world of KIRs, for always having time for my 
questions, for calming me down when I think I am about to get scooped and for all parenting 
talks J Iva, for great discussions and chats, for being an inspiring researcher, I enjoyed 
working together for you! Andrea, even though we worked together only briefly, for all the 
good mood in the office and for our flowjo/R feedback sessions. Lena, for sectioning and 
staining all those samples when the deadline was suddenly approaching again. Isabelle, it 
was great to have had you in our group, it was admiring to see your positive attitude and I 
wish you all the best for your future!  
Jonna, for taking on every task no matter if I once again planned way too much! And for 
bearing with me when I again suddenly disappeared to meetings J It was great that I could 
accompany you all the way from the first flow cytometry steps, over confusing CXCR 
stainings to now quickly reshuffling a Symphony panel. I enjoyed all work with you and wish 
you all the best for your future! 
Laura, for bringing good mood and electronic music to the lab – despite our very different 
working hours J and more importantly, a million times thank you for being such a great 
person! One that also my kids adore – it was great to have somebody like you that also we 
parents could go to town. Thank you! You will be missed at CIM! 
Martin C, I don’t even know where to start. It feels already like we are married after all those 
years sitting next to each other! Thanks for always coming up with a new statistic test I had 
not heard before –  but maybe this is just another trick to tease me, who knows. I am really 
happy that we started at the same time and that I had not only a great person next to me but 
also a great researcher! Thus, for once, not a too mean Benedikt J thank you! 
Ylva, I am so happy that we worked together! Not only are you a great person, but also great 
researcher and clinician. It was so nice to get to know you and your family. Don’t forget, next 
time will be Bavaria again! 
 
 37 
Julia, it was just awesome to start my PhD in a collaboration with you! It is fair to say that 
this thesis would not be what it is without you. Thank you also for all the fun we had at after-
works, for looking after my kids (they still remember you!). Thus, I am just grateful to have 
worked with you and I wish you all best for your future! 
To Tanvi, for great collaborations and for being such a good spirit! Also thank you to 
Christian, for not being afraid of my big experiments and for being an enthusiastic young 
researcher! 
To Sebastian, for the good collaboration and bringing in the crucial clinical side to our 
research and for making the meetings less dry with some humour! 
The other members of the sexy green office, Ginny, JB, Anna and Thea, for making it a joy 
to go to work! Anna, you are missed, it was great to have you! Thea, great that you made it 
to our office, thanks for all talks! JB, thank you for bringing so much good mood to the 
office, for organizing all the after-works and our Årsta swim-runs. And it was amazing to see 
that one does not have to have a backpack full with stuff on the way to work. Dearest Ginny, 
there is so much to thank you for!! Not only all chats, the cycling, the passion for food, also 
your sense of humour, even though that latter ends if the jokes are about English Cheddar. 
Learned that lesson J stay as you are! 
Kimia, thank you for always being positive, it is a joy being around you! Caroline, Ebba, 
Tiphaine, Quirin, Alvaro, Luca, Renata, Elza, Osh, Tyler, Nicole, Angelica, Marina, 
Egle, Puran, Jakob for all fun in the lab, in the breaks and at after-works. Aline, it was great 
to have you around! Leni for the cycling company and Lamberto for your sense of humour! 
Thanks to all other members at CIM and Non-CIMers that I cannot thank on these pages – 
otherwise I would end up with 20 pages acknowledgements J  
To all friends in Germany that supported me and made Sweden feel less far away: Matze, 
Laura, Mario, Rosa, Magdalena, Lukas, Niko, Astrid, Alex, Christine, Yvy, Rainer, 
Sonja, Andreas, Dominik, Leni, Verena Heidi, Mattis, Paul and Fabian!  
A big thank you also to my group of friends here in Sthlm: Dirk und Konrad, welche 
glueckliche Fuegung das Kinderschwimmen in Tyresö doch ist! Danke fuer sämtliche 
Unternehmungen mit oder ohne Kinder, ob am Fels oder auf dem Wasser! Ebenso danke an 
Christian und Ulf, fuer lustige Abende, segel Abenteuer, Årsta Schwimm-Runden und 
Ferien in Enskede! 
And last but definitely not least, my family: First, to my love Nina, for taking on this 
adventure of moving as a family to another country, for bearing with me when I found it a fun 
evening entertainment to analyze Flowjo data, for supporting me, for reminding me that some 
things other than NK cells are important and still listening to the cryptic list of CD molecules 
that I talk about! My kids, even though only Ronja and Marie might be able to recognize 
their names and the following smiley J It is indeed refreshing to stop the research thoughts 
and to color a painting instead. My siblings Sebastian and Lisi for their support. Then my 
parents Christine and Max, for the tremendous support from early on and throughout the 
years, for sending packages to Sweden to keep parents and kids happy, for visiting as if there 
was no distance between the two countries… I cannot thank you enough! 
Writing these acknowledgements made me realize why this PhD was possible – thus a last 
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